EFFICACY OF GIKM (GLUCOSE, INSULIN, POTASSIUM, MAGNESIUM) THERAPY IN THE MANAGEMENT OF MYOCARDIAL INFARCTION COMPAIRED TO CURRENT THROMBOLYTIC THERAPY: A DOUBLE BLIND RANDOMIZED CLINICAL TRIAL
Introduction. Although common theraputic methods for myocardial infarction are conducted, mortality and morbidity of this disease are high, yet. Therefore, finding a new economical therapies such as metabolic modulation of ischemic myocardial muscle with thrombolytic therapy can somehow improves thi...
Main Authors: | M GARAK YARAGHI, M KIANJOO, M MORTAZAVI, N SARRAFZADEGAN, H SHEMIRANI, M SHAHPARIAN |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2001-09-01
|
Series: | Journal of Research in Medical Sciences |
Subjects: | |
Online Access: | http://journals.mui.ac.ir/jrms/article/view/3412 |
Similar Items
-
The efficacy of pharmaceutical combination of glucose, insulin, potassium, and magnesium along with thrombolytic therapy on the mortality of patients with acute myocardial infarction
by: Mohammad Garakyaraghi, et al.
Published: (2012-03-01) -
Thrombolytic Therapy in Acute Stroke
by: Yen-Wei Hsu, et al.
Published: (2008-09-01) -
THROMBOLYTIC THERAPY IN PATIENTS WITH MYOCARDIAL INFARCTION
by: G. P. Ishmurzin, et al.
Published: (2010-12-01) -
EVOLUTION OF THROMBOLYTIC THERAPY IN THE TREATMENT OF MYOCARDIAL INFARCTION
by: P. G. Kesov, et al.
Published: (2015-09-01) -
COMPLICATIONS OF THROMBOLYTIC THERAPY IN ACTUAL CLINICAL PRACTICE
by: A. F. Sharafutdinova, et al.
Published: (2014-07-01)